A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Clinical trial NCT03803761 · WITHDRAWN

Trial details

NCT number: NCT03803761
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma Metastatic Malignant Neoplasm in the Brain Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2019-02-13
Primary completion: 2022-02-19
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.